Recent News

By Region: North America

Anthrax continues to haunt farms, livestock in southern Italy

(Washington Post) Anthrax, a deadly animal disease used in biological warfare, is spreading in southern Italy, killing livestock on farms as far as 50 kilometers (31 miles) from where three outbreaks were reported a week ago. The illness killed cattle, …

PharmAthene Awarded 50% Profit Split on Worldwide Sales of Smallpox Antiviral

(PR Newswire) PharmAthene filed the lawsuit against SIGA in December 2006 citing PharmAthene's interest in ST-246, an orally available smallpox antiviral drug candidate. "We are extremely pleased with the Court's decision," remarked Eric I. Richman, President and …

Fact Sheet: Global Health Security

(Whitehouse.gov) Through fora such as the UN Security Resolution 1540, the Biological Weapons Convention (BWC), and the World Health Organization (WHO), the United States is pursuing a common vision where disease no longer threatens the security and prosperity of …

HHS anthrax vaccine advisors weigh pediatric use

(CIDRAP) However, no studies have been conducted in children, who make up 25% of the US population, though federal bioterror response plans call for both groups to receive three doses of the vaccine, alongside antibiotic prophylaxis, after an anthrax attack. …

PharmAthene Receives Court Decision on Smallpox Drug Dispute

(Metro Business Media) PharmAthene Receives Court Decision on Smallpox Drug DisputeMetro Business MediaBased upon today's ruling, PharmAthene was awarded 50% of net profits for worldwide sales of ST-246, an orally available smallpox antiviral drug candidate, for ten years pursuant to SIGA receiving $40 million in upfront payments. …